LncRNA DCRT 通过结合 PTBP1 防止 NDUFS2 异常剪接从而保护扩张型心肌病
该研究探索心脏富集长链非编码 RNA DCRT 在扩张型心肌病中的作用。DCRT 在患者心肌中表达下调,敲除小鼠自发出现心功能障碍和线粒体损伤,其机制为 DCRT 结合 PTBP1 抑制 NDUFS2 第三外显子跳跃,而该跳跃会抑制线粒体复合物 I 活性并削弱 PRDX5 抗氧化功能;补充辅酶 Q10 可部分缓解。
要点
- DCRT 在扩张型心肌病患者心肌中表达显著下调。
- DCRT 通过结合 PTBP1 抑制 NDUFS2 第三外显子跳跃,维持线粒体功能。
- 辅酶 Q10 可部分缓解 DCRT 减少所致的心肌细胞线粒体功能障碍。
核心结论
- DCRT 缺失通过 PTBP1 介导的 NDUFS2 外显子跳跃导致心脏线粒体功能障碍,促进扩张型心肌病发展。
研究设计与样本
- 使用 CRISPR-Cas9 技术构建 DCRT 敲除小鼠和敲除细胞。
- 利用 α-肌球蛋白重链启动子构建心脏特异性 DCRT 转基因小鼠。
主要发现
- DCRT 在正常心脏组织中高度富集,在扩张型心肌病患者心肌中表达显著下调。
- DCRT 敲除小鼠自发出现心功能障碍、心脏扩大和线粒体损伤。
- DCRT 转基因或重组腺相关病毒系统过表达减轻横向主动脉缩窄引起的心功能障碍。
- DCRT 在心肌细胞核内直接结合 PTBP1,抑制 NDUFS2 第三外显子跳跃。
- NDUFS2 第三外显子跳跃通过竞争性抑制线粒体复合物 I 活性及结合 PRDX5 抑制其抗氧化活性,诱导线粒体功能障碍。
临床怎么用
- 辅酶 Q10 补充可部分缓解 DCRT 减少引起的心肌细胞线粒体功能障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dilated cardiomyopathy is characterized by left ventricular dilation and continuous systolic dysfunction. Mitochondrial impairment is critical in dilated cardiomyopathy; however, the underlying mechanisms remain unclear. Here, we explored the cardioprotective role of a heart-enriched long noncoding RNA, the dilated cardiomyopathy repressive transcript (DCRT), in maintaining mitochondrial function. METHODS: The DCRT knockout (DCRT-/-) mice and DCRT knockout cells were developed using CRISPR-Cas9 technology. Cardiac-specific DCRT transgenic mice were generated using α-myosin heavy chain promoter. Chromatin coimmunoprecipitation, RNA immunoprecipitation, Western blot, and isoform sequencing were performed to investigate the underlying mechanisms. RESULTS: We found that the long noncoding RNA DCRT was highly enriched in the normal heart tissues and that its expression was significantly downregulated in the myocardium of patients with dilated cardiomyopathy. DCRT-/- mice spontaneously developed cardiac dysfunction and enlargement with mitochondrial impairment. DCRT transgene or overexpression with the recombinant adeno-associated virus system in mice attenuated cardiac dysfunction induced by transverse aortic constriction treatment. Mechanistically, DCRT inhibited the third exon skipping of NDUFS2 (NADH dehydrogenase ubiquinone iron-sulfur protein 2) by directly binding to PTBP1 (polypyrimidine tract binding protein 1) in the nucleus of cardiomyocytes. Skipping of the third exon of NDUFS2 induced mitochondrial dysfunction by competitively inhibiting mitochondrial complex I activity and binding to PRDX5 (peroxiredoxin 5) and suppressing its antioxidant activity. Furthermore, coenzyme Q10 partially alleviated mitochondrial dysfunction in cardiomyocytes caused by DCRT reduction. CONCLUSIONS: Our study revealed that the loss of DCRT contributed to PTBP1-mediated exon skipping of NDUFS2, thereby inducing cardiac mitochondrial dysfunction during dilated cardiomyopathy development, which could be partially treated with coenzyme Q10 supplementation.
引用
- Du H, Zhao Y, Wen J, et al. LncRNA DCRT Protects Against Dilated Cardiomyopathy by Preventing NDUFS2 Alternative Splicing by Binding to PTBP1. Circulation. 2024. PMID: 38841852. doi:10.1161/CIRCULATIONAHA.123.067861
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。